Analysis of the TNFRI promoter at position −201 showed a significant decrease in the frequency of the −201T allele within the PTLD group compared with the transplant control group (45% vs 29%, P=0.02; Figure 1B;, Table 1). This evidence concerns the gene TNFRSF1A and post-transplant lymphoproliferative disease.